Dear Editor,
Congenital heart disease (CHD) is the leading cause of death in Down syndrome (DS) children below the age of 2. The prevalence of CHD in DS has been reported to be between 40-63 % in multiple studies (Benhaourech et al., 2016) . A retrospective study was performed to evaluate the risks of congenital cardiac defects in DS patients aged less than 21.
The 2012 The Down syndrome cell adhesion molecule (DSCAM) is involved in adhesion as well as fusion of endocardial cushions. In Down syndrome patients, there is overexpression of the DSCAM gene that leads to an imbalance in the epithelial-mesenchymal transformation. It can also cause a defect in mesenchymal migration and proliferation that eventually causes several congenital heart defects (Marder et al., 2015) . AVSDs have also been linked with extracellular matrix anomalies and it is believed that TOF can be a result of multiple anomalies involving ectomesenchymal tissue migration (Moreno Garcia et al., 2000) .
While our results confirm the increased risk of multiple congenital cardiac defects in children with Down syndrome, there are some limitations to the use of HCUP database. It does not allow access to investigate follow-ups of patients and can be influenced by input mistakes. 
